Viking Therapeutics, Inc. (VKTX)

33.00 +1.49 (+4.73%) USD  |  NASDAQ  |  Mar 06, 16:00
33.00 0.00 (0.00%) After-Hours: 20:00
More

Viking Therapeutics Payables and Accrued Expenses (Quarterly)

Payables and Accrued Expenses (Quarterly) Chart

View Payables and Accrued Expenses (Quarterly) for VKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Payables and Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Payables and Accrued Expenses (Quarterly) Benchmarks

View Payables and Accrued Expenses (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Amgen, Inc. Upgrade
Pfizer Inc. Upgrade
Hims & Hers Health, Inc. Upgrade
Altimmune, Inc. Upgrade